1. Benjamin EJ, Wolf PA, D’Agostino RB, et al. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 1998;98:946–952.
2. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 1991;22:983–988.
3. Levy S, Maarek M, Coumel P, et al. Characterization of different subsets of atrial fibrillation in general practice in France: the ALFA study. Circulation 1999; 99:3028–3035.
4. Roberts JD, Gollob MH. Impact of genetic discoveries on the classification of lone atrial fibrillation. J Am Coll Cardiol 2010;55:705–712.
5. Olesen MS, Nielsen MW, Haunso S, et al. Atrial fibrillation: the role of common and rare genetic variants. Eur J Hum Genet 2014;22:297–306.
6. Ellinor PT, Lunetta KL, Albert CM, et al. Large scale replication and metaanalysis of variants on chromosome 4q25 associated with atrial fibrillation. Eur Heart J 2008;30:813–819.
7. Gudbjartsson DF, Arnar DO, Helgadottir A, Gretarsdottir S, et al. Variants conferring risk of atrial fibrillation on chromosome 4q25. Nature 2007; 448:353–357.
8. Roselli C, Chaffin MD, Weng LC, et al. Multi-ethnic genome-wide association study for atrial fibrillation. Nat Genet 2018;50:1225–1233.
9. Sinner MF, Tucker NR, Lunetta KL, et al. Integrating genetic, transcriptional, and functional analyzes to identify 5 novel genes for atrial fibrillation. Circulation 2014;130:1225–1235.
10. Low SK, Takahashi A, Ebana Y, et al. Identification of six new genetic loci associated with atrial fibrillation in the Japanese population. Nat Genet 2017; 49:953–958.
11. Christophersen IE, Rienstra M, Roselli C, et al. Large-scale analyses of common and rare variants identify 12 new loci associated with atrial fibrillation. Nat Genet 2017;49:946–952.
12. Schnabel RB, Sullivan LM, Levy D, et al. Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study. Lancet 2009;373:739–745.
13. Chamberlain AM, Agarwal SK, Folsom AR, et al. A clinical risk score for atrial fibrillation in a biracial prospective cohort (from the Atherosclerosis Risk in Communities [ARIC] study). Am J Cardiol 2011;107:85–91.
14. Kokubo Y, Watanabe M, Higashiyama A, et al. Development of a basic risk score for incident atrial fibrillation in a japanese general population—The Suita Study. Circ J 2017;81:1580–1588.
15. Suzuki A, Yamada R, Chang X, et al. Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis. Nat Genet 2003;34:395–402.
16. Siontis KC, Gersh BJ, Killian JM, et al. Typical, atypical, and asymptomatic presentations of new-onset atrial fibrillation in the community: characteristics and prognostic implications. Heart Rhythm 2016;13:1418–1424.
17. Fox CS, Parise H, D’ Agostino RB Sr, et al. Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring. JAMA 2004;291:2851–2855.
18. Lin H, Dolmatova EV, Morley MP, et al. Gene expression and genetic variation in human atria. Heart Rhythm 2014;11:266–271.
19. Garnier S, Villard E, Hengstenberg C, et al. Involvement of BAG3 and HSPB7 loci in various etiologies of systolic heart failure: results of a European collaboration assembling more than 2,000 patients. Int J Cardiol 2015;189:105–107.
20. Benjamin EJ, Rice KM, Arking DE, et al. Variants in ZFHX3 are associated with atrial fibrillation in individuals of European ancestry. Nat Genet 2009; 41:879–881.
21. Liu L, Ebana Y, Nitta J, et al. Genetic variants associated with susceptibility to atrial fibrillation in a Japanese population. Can J Cardiol 2017;33:443–449.
22. Muse ED, Wineinger NE, Spencer EG, et al. Validation of a genetic risk score for atrial fibrillation: a prospective multicenter cohort study. PLoS Med 2018; 15:e1002525.
23. Christophersen IE, Ravn LS, Budtz-Joergensen E, et al. Familial aggregation of atrial fibrillation: a study in Danish twins. Circ Arrhythm Electrophysiol 2009; 2:378–383.
24. Said MA, Verweij N, van der Harst. Associations of combined genetic and lifestyle risks with incident cardiovascular disease and diabetes in the UK Biobank Study. JAMA Cardiol 2018;3:693–702.
25. Weng LC, Presis SR, Hulme OL, et al. Genetic predisposition, clinical risk factor burden, and lifetime risk of atrial fibrillation. Circulation 2018;137:1027–1038.